...
首页> 外文期刊>The Journal of investigative dermatology. >MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphoma
【24h】

MicroRNA Expression Profiling and DNA Methylation Signature for Deregulated MicroRNA in Cutaneous T-Cell Lymphoma

机译:MicroRNA表达谱和DNA甲基化签名的皮肤T细胞淋巴瘤中的MicroRNA失控。

获取原文
获取原文并翻译 | 示例

摘要

MicroRNAs usually regulate gene expression negatively, and aberrant expression has been involved in the development of several types of cancers. Microarray profiling of microRNA expression was performed to define a microRNA signature in a series of mycosis fungoides tumor stage (MFt, n=21) and CD30+ primary cutaneous anaplastic large cell lymphoma (CD30+ cALCL, n=11) samples in comparison with inflammatory dermatoses (ID, n=5). Supervised clustering confirmed a distinctive microRNA profile for cutaneous T-cell lymphoma (CTCL) with respect to ID. A 40 microRNA signature was found in MFt including upregulated onco-microRNAs (miR-146a, miR-142-3p/5p, miR-21, miR-181a/b, and miR-155) and downregulated tumor-suppressor microRNAs (miR-200ab/429 cluster, miR-10b, miR-193b, miR-141/200c, and miR-23b/27b). Regarding CD30+ cALCL, 39 differentially expressed microRNAs were identified. Particularly, overexpression of miR-155, miR-21, or miR-142-3p/5p and downregulation of the miR-141/200c clusters were observed. DNA methylation in microRNA gene promoters, as expression regulatory mechanism for deregulated microRNAs, was analyzed using Infinium 450K array and approximately one-third of the differentially expressed microRNAs showed significant DNA methylation differences. Two different microRNA methylation signatures for MFt and CD30+ cALCL were found. Correlation analysis showed an inverse relationship for microRNA promoter methylation and microRNA expression. These results reveal a subgroup-specific epigenetically regulated microRNA signatures for MFt and CD30+ cALCL patients.
机译:MicroRNA通常会对基因表达产生负调控,并且异常表达已参与多种类型癌症的发展。进行微阵列表达的微阵列分析,以定义一系列真菌病真菌分期(MFt,n = 21)和CD30 +原发性皮肤间变性大细胞淋巴瘤(CD30 + cALCL,n = 11)样品中的微RNA标记,与炎症性皮肤病( ID,n = 5)。有监督的聚类证实了针对皮肤T细胞淋巴瘤(CTCL)的ID具有独特的microRNA谱。在MFt中发现了40个microRNA标记,包括上调的癌微RNA(miR-146a,miR-142-3p / 5p,miR-21,miR-181a / b和miR-155)和下调的肿瘤抑制microRNA(miR- 200ab / 429簇,miR-10b,miR-193b,miR-141 / 200c和miR-23b / 27b)。关于CD30 + cALCL,鉴定了39个差异表达的微小RNA。特别是,观察到miR-155,miR-21或miR-142-3p / 5p的过表达和miR-141 / 200c簇的下调。使用Infinium 450K阵列分析了microRNA基因启动子中的DNA甲基化,作为表达失调的microRNA的表达调控机制,大约有三分之一的差异表达的microRNA显示出明显的DNA甲基化差异。发现了MFt和CD30 + cALCL的两个不同的microRNA甲基化标记。相关分析表明,microRNA启动子甲基化与microRNA表达呈反比关系。这些结果揭示了MFt和CD30 + cALCL患者的亚组特异性表观遗传调控的microRNA特征。

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号